For an adult postoperative patient with hypotension due to volume depletion after non‑septic surgery, normal renal function (eGFR ≥ 60 mL/min/1.73 m²) and no active coagulopathy, should I use 6 % hydroxyethyl starch (HES 130/0.4) and what dose is appropriate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydroxyethyl Starch in Postoperative Hypotension

Primary Recommendation

Do not use 6% hydroxyethyl starch (HES 130/0.4) for postoperative hypotension—use balanced crystalloids (lactated Ringer's or Plasma-Lyte) as first-line therapy instead. 1

The most recent high-quality guidelines from the British Journal of Anaesthesia (2024) provide a strong recommendation against routine use of synthetic colloids including HES for intraoperative or postoperative fluid administration, based on high-quality evidence. 1


Why HES Should Be Avoided

Renal Toxicity

  • HES increases the risk of acute kidney injury even in surgical patients with normal baseline renal function, despite your patient having eGFR ≥60 mL/min/1.73 m². 1
  • The FLASH study demonstrated significantly higher renal failure rates with HES (relative risk 1.34, p=0.05) during major abdominal surgery. 1
  • Multiple studies show HES causes a decline in GFR of approximately 7 mL/min/1.73 m² per unit administered in the early postoperative period. 2, 3
  • Cardiac surgery patients receiving HES as pump prime had twice the risk of postoperative AKI (adjusted OR 2.26; 95% CI 1.40-3.80). 2

Coagulopathy and Bleeding Risk

  • HES is associated with hemostasis disorders and significantly higher hemorrhagic risk compared to crystalloids in major non-cardiovascular surgery. 1
  • This results in higher transfusion requirements in surgical patients. 1
  • The risk of surgical revision for bleeding is significantly increased (4.6% vs 1.4%, p=0.02). 2

No Mortality or Morbidity Benefit

  • Meta-analyses show no improvement in mortality, major complications, or composite outcomes when comparing HES to crystalloids in surgical patients. 1
  • The volume-sparing effect of HES is overestimated—the actual crystalloid-to-colloid ratio is approximately 1.8:1, not the commonly believed 3-4:1. 4

What to Use Instead: Balanced Crystalloids

First-Line Therapy

  • Administer balanced crystalloids (lactated Ringer's or Plasma-Lyte) for postoperative hypotension due to volume depletion. 1
  • These solutions reduce the risk of acute kidney injury compared to 0.9% saline. 1

Dosing Strategy

  • Aim for a mildly positive fluid balance of +1-2 liters by the end of resuscitation to protect kidney function while avoiding fluid overload. 1
  • Administer fluid boluses guided by hemodynamic parameters (mean arterial pressure, heart rate, urine output). 1
  • If using 0.9% saline, limit to maximum 1-1.5 liters to minimize hyperchloremic acidosis risk. 1

Avoid Excessive Restriction

  • Stringently restrictive "zero-balance" fluid strategies increase AKI risk compared to modestly liberal regimens. 1
  • A body weight increase of approximately 1.6 kg within 24 hours postoperatively is acceptable and protective. 1

Critical Caveats

When HES Might Still Be Encountered

  • While the 2026 PHOENICS trial (1,985 patients) showed non-inferiority of HES for short-term renal function in elective abdominal surgery 5, this does not override the strong guideline recommendations against routine use. 1
  • The trial showed HES caused greater eGFR decline (-3.4 vs -1.0 mL/min/1.73 m²) despite meeting non-inferiority margins. 5
  • Guidelines explicitly state HES should not be used until new evidence emerges, and one positive trial does not constitute sufficient evidence to change practice. 1, 6

Regulatory Context

  • The European Medicines Agency recommended in 2013 that HES no longer be used for volume resuscitation. 7
  • French health authorities restrict HES to second-line treatment only when crystalloids are deemed insufficient. 1
  • HES is absolutely contraindicated in critically ill patients, sepsis, severe liver disease, and pre-existing coagulopathy. 6, 7

Common Pitfall

  • Do not be misled by the belief that colloids provide superior hemodynamic support—the crystalloid-to-colloid equivalence ratio is approximately 1:1 in terms of volume-sparing effects. 1
  • Studies claiming HES superiority typically used inadequate control fluids (other colloids or 0.9% saline rather than balanced crystalloids) and were too small and short-duration to detect safety signals. 4

Practical Algorithm for Postoperative Hypotension

  1. Confirm volume depletion as the cause (vs. vasodilation, cardiac dysfunction, bleeding).
  2. Administer balanced crystalloid boluses (250-500 mL) guided by hemodynamic response.
  3. Reassess after each bolus—check blood pressure, heart rate, urine output, and clinical perfusion.
  4. Continue crystalloids until euvolemia is achieved, targeting +1-2 L positive balance overall.
  5. Add vasopressors (norepinephrine or phenylephrine) if hypotension persists despite adequate volume replacement.
  6. Never use HES as first-line or routine therapy—the risks outweigh any theoretical benefits. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.